The second edition of Innovabiomed 2021, the network place for biomedical innovation to be held at the Palaexpo Congress Center in Verona, has been rescheduled from 2 to 3 July.
The new dates will allow the event to be held totally in person, in safe conditions that will encourage networking activities between operators in the sector.
The aim will be to create opportunities for meetings and discussions between experts in the production of medical devices, professionals and researchers in the sector, connecting different disciplines, skills and professionalisms.
Innovabiomed’s partners are Confindustria Medical Devices and Confimi Sanità. Organizing partner is RPM Media.
Organized by Veronafiere, the event also sees the collaboration with distrettobiomedicale.it , the reference portal of the Mirandolese district, the main biomedical center in Europe. In the Innovabiomed 2021 program, conferences, round tables, workshops and a business area with the presence of highly innovative companies.
Digital health, robotics, 3D printing, regenerative medicine, artificial intelligence and precision oncology are just some of the topics that will be addressed during the two days with the contribution of over 50 speakers, among the top experts in the sector, selected by the scientific committee of the ‘event.
Maurizio Danese, president of Veronafiere: “Innovabiomed 2021 is the first event dedicated to the biomedical sector to be held in attendance since the beginning of the pandemic. This testifies to the great attention we pay to the medical-scientific community and to companies in the sector, fundamental for its social value and of which Italy is the European leader. A primacy that however requires continuous investments in research and innovation: it is precisely in this direction that the fair is looking, a moment of promotion for the business of companies but also of comparison, thanks to meetings and conferences of the highest profile ».
The health emergency linked to Covid-19 highlighted how the transversal knowledge underlying the development of biomedical devices and, in general, innovation in the medical field – from biology to electronics, from information technology to materials engineering – are important for saving lives.
In fact, technological innovation contributes significantly to improving the health of patients and medical devices represent one of the sectors with the highest unemployment rate. The sector in Italy generates a market worth 16.7 billion euros between exports and the domestic market and has 4,323 companies, which employ 94,153 employees (Confindustria Medical Devices data).